After privately vying for a change to Dynavax’s corporate strategy for months, life sciences investment firm Deep Track ...

To McIntosh, the most surprising bankruptcy of 2024 was Eiger BioPharmaceuticals, a metabolic disease biotech that was ...

In the bill, the Mississippi Department of Health will be tasked with conducting a “comprehensive correctional services review” of all medical care provided to state inmates.

As Valentine's Day approaches, let us remember that love isn't just about grand gestures it's about the conversations that ...

Doctor holds in one hand laboratory holds blood sample positive with hepatitis C virus label, other handwriting down results to patients medical record. Laboratory medical diagnostics The doctor holds ...

EMERYVILLE, CA - Dynavax Technologies Corporation (NASDAQ:DVAX), a biopharmaceutical firm valued at $1.68 billion, has entered into a material definitive agreement with West Pharmaceutical Services ...

In 1972, the year Cheng finished his Ph.D. in pharmacology at Brown University ... developing antiviral drugs for chronic diseases, such as hepatitis B. But he has also wondered whether there ...

While the measles-mumps-rubella vaccine is perhaps the best known, the recommended inoculations target such diseases as rotavirus, diphtheria, hepatitis A and B ... do not affect the recipient’s ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

Infection with hepatitis D viruses causes severe inflammation of the liver. An MHH team has now identified a marker on natural killer cells that is influenced by the anti-inflammatory ...

The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...